These patients displayed the typical CNAs observed in prostate cancer, including recurrent allelic gains of MYC and deletions of PTEN, TP53, and NKX3.1; the percentage of genome affected by CNAs was highly variable in these tumors [62]. Here, PTEN is linked to prostate cancer.